Argent Trust Co’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Sell |
-6,454
| Closed | -$566K | – | 484 |
|
2020
Q4 | $566K | Buy |
6,454
+690
| +12% | +$60.5K | 0.04% | 299 |
|
2020
Q3 | $438K | Buy |
5,764
+2,142
| +59% | +$163K | 0.04% | 313 |
|
2020
Q2 | $447K | Buy |
3,622
+346
| +11% | +$42.7K | 0.04% | 305 |
|
2020
Q1 | $277K | Sell |
3,276
-640
| -16% | -$54.1K | 0.03% | 341 |
|
2019
Q4 | $331K | Sell |
3,916
-965
| -20% | -$81.6K | 0.03% | 366 |
|
2019
Q3 | $329K | Buy |
4,881
+615
| +14% | +$41.5K | 0.03% | 362 |
|
2019
Q2 | $365K | Buy |
4,266
+717
| +20% | +$61.3K | 0.04% | 335 |
|
2019
Q1 | $315K | Buy |
3,549
+516
| +17% | +$45.8K | 0.03% | 351 |
|
2018
Q4 | $258K | Sell |
3,033
-650
| -18% | -$55.3K | 0.03% | 370 |
|
2018
Q3 | $357K | Sell |
3,683
-38
| -1% | -$3.68K | 0.04% | 320 |
|
2018
Q2 | $349K | Sell |
3,721
-1,638
| -31% | -$154K | 0.04% | 327 |
|
2018
Q1 | $434K | Sell |
5,359
-851
| -14% | -$68.9K | 0.12% | 176 |
|
2017
Q4 | $554K | Buy |
6,210
+268
| +5% | +$23.9K | 0.22% | 136 |
|
2017
Q3 | $553K | Sell |
5,942
-309
| -5% | -$28.8K | 0.22% | 140 |
|
2017
Q2 | $568K | Sell |
6,251
-342
| -5% | -$31.1K | 0.23% | 133 |
|
2017
Q1 | $579K | Sell |
6,593
-1,025
| -13% | -$90K | 0.24% | 130 |
|
2016
Q4 | $631K | Sell |
7,618
-918
| -11% | -$76K | 0.28% | 112 |
|
2016
Q3 | $790K | Sell |
8,536
-257
| -3% | -$23.8K | 0.34% | 88 |
|
2016
Q2 | $684K | Buy |
8,793
+1,401
| +19% | +$109K | 0.3% | 98 |
|
2016
Q1 | $610K | Buy |
7,392
+23
| +0.3% | +$1.9K | 0.3% | 105 |
|
2015
Q4 | $772K | Buy |
7,369
+467
| +7% | +$48.9K | 0.38% | 79 |
|
2015
Q3 | $727K | Sell |
6,902
-32
| -0.5% | -$3.37K | 0.41% | 78 |
|
2015
Q2 | $948K | Sell |
6,934
-165
| -2% | -$22.6K | 0.48% | 63 |
|
2015
Q1 | $885K | Buy |
7,099
+480
| +7% | +$59.8K | 0.45% | 69 |
|
2014
Q4 | $598K | Buy |
+6,619
| New | +$598K | 0.36% | 88 |
|